All News about Vyant Bio, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image47.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/04/analysis-g1b708250b_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/05/image29.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_326.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Intraday Session
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_277.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/05/image31_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/05/image-walgreens_boots_alliance.jpg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_24268.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_24175.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23911.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Wednesday
December 21, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23753.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Monday
December 19, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21987.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21656.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Thursday
November 17, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/115addcb-7597-44c9-bad4-a3db5c719fa6/small/logo-png.png)
![](https://ml.globenewswire.com/media/115addcb-7597-44c9-bad4-a3db5c719fa6/small/logo-png.png)
Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 16, 2022
From Vyant Bio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/115addcb-7597-44c9-bad4-a3db5c719fa6/small/logo-png.png)
![](https://ml.globenewswire.com/media/115addcb-7597-44c9-bad4-a3db5c719fa6/small/logo-png.png)
![](https://ml.globenewswire.com/media/115addcb-7597-44c9-bad4-a3db5c719fa6/small/logo-png.png)
![](https://ml.globenewswire.com/media/115addcb-7597-44c9-bad4-a3db5c719fa6/small/logo-png.png)
![](https://ml.globenewswire.com/media/115addcb-7597-44c9-bad4-a3db5c719fa6/small/logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20757.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/03/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image42.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20446.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Tuesday
November 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image29.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free